-
Jun 18, 2025, 4:29 pm42 ptsPharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more than 99.9 percent effective among participants. Gilead's product Yeztugo, a form of lenacapavir, was…
Israeli Strikes Hit Iran's Underground Nuclear Facility, UN Atomic Watchdog Confirms Washington Free Beacon 190
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.